| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.08 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |